Knockdown of PEDF in OM-MSCs counteracted its capacity to upregulate the ratio of p-Akt/Akt and p-mTOR/mTOR in N2a cells after OGD/R (Figures 4(a) and 4(b)). The gene discussed is MTOR; the disease is ocular melanoma.